Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.125
-0.035 (-3.02%)
Jun 24, 2026, 1:33 PM EDT - Market open
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $145.47 million as of June 24, 2026. Its market cap has decreased by -8.09% in one year.
Market Cap
145.47M
Enterprise Value
141.27M
1-Year Change
-8.09%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has decreased from $145.96M to $145.47M, a decrease of -0.33%. That is a compound annual growth rate of -0.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 145.47M | -17.84% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kazia Therapeutics | 159.98M |
| Corbus Pharmaceuticals Holdings | 153.97M |
| Tenaya Therapeutics | 151.90M |
| Spruce Biosciences | 150.55M |
| Cognition Therapeutics | 150.36M |
| Enlivex | 150.17M |
| Alpha Cognition | 149.48M |
| NRx Pharmaceuticals | 141.16M |